Mounjaro, Zepbound Lowers Diabetes Risk By 94%, Eli Lilly Trial Shows
In a new clinical trial, the GLP-1 drug tirzepatide was effective in helping people maintain weight loss over a 3-year period. Researchers reported the resulting weight loss also lowered participants’…